Edition:
United Kingdom

Spark Therapeutics Inc (ONCE.OQ)

ONCE.OQ on NASDAQ Stock Exchange Global Select Market

45.08USD
18 Jan 2019
Change (% chg)

$1.19 (+2.71%)
Prev Close
$43.89
Open
$44.00
Day's High
$45.76
Day's Low
$43.55
Volume
117,355
Avg. Vol
212,386
52-wk High
$96.51
52-wk Low
$34.59

Chart for

About

Spark Therapeutics, Inc. is a gene therapy company. The Company focuses on treating orphan diseases. It has a pipeline of product candidates targeting multiple rare blinding conditions, hematologic disorders and neurodegenerative diseases. Its pipeline includes a product candidate targeting choroideremia (CHM), which is in a... (more)

Overall

Beta: --
Market Cap(Mil.): $3,132.52
Shares Outstanding(Mil.): 35.82
Dividend: --
Yield (%): --

Financials

  ONCE.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -6.38 -- --
ROI: -61.15 8.99 14.48
ROE: -63.88 10.13 15.99

BRIEF-European Commission Approves Spark Therapeutics' Luxturna

* EUROPEAN COMMISSION APPROVES SPARK THERAPEUTICS' LUXTURNA® (VORETIGENE NEPARVOVEC), A ONE-TIME GENE THERAPY FOR INHERITED RETINAL DISEASE CAUSED BY CONFIRMED BIALLELIC RPE65 MUTATIONS Source text for Eikon: Further company coverage:

23 Nov 2018

Earnings vs. Estimates